In the end, we identified six genes (DLGAP5, DSCC1, SSBP1, UBE2C, SNRPD1, and SMO) with a vital role in prevention of cell death in both cell lines and hence six potential drug targets for silencing in cancer therapy. This evidence concerns the gene DLGAP5 and cancer.